Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Gw Pharma Limited patents


Recent patent applications related to Gw Pharma Limited. Gw Pharma Limited is listed as an Agent/Assignee. Note: Gw Pharma Limited may have other listings under different names/spellings. We're not affiliated with Gw Pharma Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Gw Pharma Limited-related inventors


Pharmaceutical formulations

The invention relates to pharmaceutical formulations for use in the administration of lipophilic medicaments via mucosal surfaces. In particular the invention provides pharmaceutical formulations for use in administration of a lipophilic medicament via a mucosal surface which upon hydration form an emulsion containing the lipophilic medicament which is capable of adhering to a mucosal surface and allowing controlled release of the medicament. ... Gw Pharma Limited

Use of cannabinoids in the treatment of degenerative skeletal muscle diseases

The present invention relates to the use of cannabinoids in the treatment of degenerative skeletal muscle disease. In particular the degenerative skeletal muscle disease is duchenne muscular dystrophy (dmd). ... Gw Pharma Limited

Extraction of pharmaceutically active components from plant materials

The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (bds) for incorporation in to a medicament. It also relates to a bds of given purity, for use in pharmaceutical formulations. ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the treatment of atonic seizures. In particular the cbd appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: lennox-gastaut syndrome; tuberous sclerosis complex; dravet syndrome; doose syndrome; aicardi syndrome; cdkl5 and dup15q in comparison to other seizure types. ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (tre). In particular, the disclosure relates to the use of cbd of treating tre when the tre is dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (fires). ... Gw Pharma Limited

Use of cannabidiol in the treatment of nocturnal snoring

The present disclosure relates to the use of cannabidiol (cbd) for the treatment of of nocturnal snoring. In particular the cbd appears particularly effective in treating nocturnal snoring in children and young adults with epilepsy the disclosure further relates to the use of cbd in combination with one or more anti-epileptic drugs (aeds).. ... Gw Pharma Limited

Use of cannabidiol in the treatment of epilepsy

The present disclosure relatesto the use of cannabidiol (cbd) for the treatment of seizures associated with aicardi syndrome. In one embodiment the seizures associated with aicardi syndrome are convulsive seizures; focal seizures with impairment or infantile spasm. ... Gw Pharma Limited

7-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsy

The present invention relates to the use of 7-hydroxy-cannabidol (7-oh-cbd) and/or 7-hydroxy-cannabidivarin (7-oh-cbdv) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.. ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (tre). In particular, the disclosure relates to the use of cbd of treating tre when the tre is dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (fires). ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (tre). In particular, the disclosure relates to the use of cbd of treating tre when the tre is dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (fires). ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (tre). In particular, the disclosure relates to the use of cbd of treating tre when the tre is dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (fires). ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the treatment of atonic seizures. In particular the cbd appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: lennox-gastaut syndrome; tuberous sclerosis complex; dravet syndrome; doose syndrome; aicardi syndrome; cdkl5 and dup15q in comparison to other seizure types. ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (tre). In particular, the disclosure relates to the use of cbd of treating tre when the tre is dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (fires). ... Gw Pharma Limited

Use of cannabinoids in the treatment of epilepsy

The present disclosure relates to the use of cannabidiol (cbd) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (tre). In particular, the disclosure relates to the use of cbd of treating tre when the tre is dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (fires). ... Gw Pharma Limited

05/11/17 / #20170128385

7-hydroxy cannabidiol (7-oh-cbd) for use in the treatment of non-alcoholic fatty liver disease (nafld)

The liver plays a key role in regulating total body energy homeostasis and its ability to do so is greatly affected by the occurrence of pathological conditions such as hepatosteatosis or non-alcoholic fatty liver disease (nafld), which contributes to hepatic insulin resistance and potentially end-stage liver disease-related mortality. Triglyceride accumulation in hepatocytes of steatotic livers results from the incorporation of plasma free fatty acids as well as de novo fat synthesis. ... Gw Pharma Limited

03/23/17 / #20170079933

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Cannabinoids, in particular cbd and cbda and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.. ... Gw Pharma Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Gw Pharma Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gw Pharma Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###